To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension
Clinical trial NCT05331014 · COMPLETED
Trial details
- NCT number
- NCT05331014
- Sponsor
- JW Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-15
- Primary completion
- 2022-11-08
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.